Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents. Issue 4 (20th June 2014)
- Record Type:
- Journal Article
- Title:
- Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents. Issue 4 (20th June 2014)
- Main Title:
- Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents
- Authors:
- Gonzalez, D
Melloni, C
Yogev, R
Poindexter, B B
Mendley, S R
Delmore, P
Sullivan, J E
Autmizguine, J
Lewandowski, A
Harper, B
Watt, K M
Lewis, K C
Capparelli, E V
Benjamin, D K
Cohen‐Wolkowiez, M
Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Clindamycin is commonly prescribed to treat children with skin and skin‐structure infections (including those caused by community‐acquired methicillin‐resistant <italic>Staphylococcus aureus</italic> (CA‐MRSA)), yet little is known about its pharmacokinetics (PK) across pediatric age groups. A population PK analysis was performed in NONMEM using samples collected in an opportunistic study from children receiving i.v. clindamycin per standard of care. The final model was used to optimize pediatric dosing to match adult exposure proven effective against CA‐MRSA. A total of 194 plasma PK samples collected from 125 children were included in the analysis. A one‐compartment model described the data well. The final model included body weight and a sigmoidal maturation relationship between postmenstrual age (PMA) and clearance (CL): CL (l/h) = 13.7 × (weight/70)<sup>0.75</sup> × (PMA<sup>3.1</sup>/(43.6<sup>3.1</sup> + PMA<sup>3.1</sup>)); <italic>V</italic> (l) = 61.8 × (weight/70). Maturation reached 50% of adult CL values at ~44 weeks PMA. Our findings support age‐based dosing.</p> <p> <italic>Clinical Pharmacology & Therapeutics</italic> (2014); <bold>96</bold> 4, 429–437. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2014.134</ext-link></p> </abstract>
- Is Part Of:
- Clinical pharmacology & therapeutics. Volume 96:Issue 4(2014)
- Journal:
- Clinical pharmacology & therapeutics
- Issue:
- Volume 96:Issue 4(2014)
- Issue Display:
- Volume 96, Issue 4 (2014)
- Year:
- 2014
- Volume:
- 96
- Issue:
- 4
- Issue Sort Value:
- 2014-0096-0004-0000
- Page Start:
- 429
- Page End:
- 437
- Publication Date:
- 2014-06-20
- Subjects:
- Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5 - Journal URLs:
- http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗ - DOI:
- 10.1038/clpt.2014.134 ↗
- Languages:
- English
- ISSNs:
- 0009-9236
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4085.xml